New View Surgical

Overview
Next-gen Medical Devices?
Product stageSegments
Go-to-Market
?
Non-implantable surgical devices
?

New View Surgical is a medical device company that has developed the VisionPort System, a novel surgical imaging and access system for minimally invasive surgery (MIS). The VisionPort System simplifies laparoscopic procedures by combining the camera and access port into a single device, eliminating the need for a separate camera port and a surgical team member to hold and manage a laparoscope.

This innovative system provides multiple advantages over traditional laparoscopic setups. It allows for multiple simultaneous views of the operative field and reduces the capital-intensive equipment required for MIS procedures. By combining six pieces of equipment needed for traditional laparoscopy into two, the VisionPort System offers clinical, operational, and financial benefits across various stakeholders.

The VisionPort System received FDA 510(k) clearance in June 2021 and is intended for use in a broad range of diagnostic and therapeutic procedures within the thoracic and abdominal cavities. It is adaptable to diverse surgical environments, representing a significant market opportunity, particularly in emerging markets where it can make state-of-the-art technology more accessible by reducing equipment costs.

In December 2022, the first commercial case utilizing the VisionPort System was performed by Dr. David Earle at Lowell General Hospital in Massachusetts, marking a milestone in the company's journey toward full commercial release planned for 2023.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
555 MASSACHUSETTS AVENUE SUITE 5 Boston MA USA
Founded year:
2009
Employees:
1-10
IPO status:
Private
Total funding:
USD 28.1 mn
Last Funding:
USD 12.1 mn (Series B; Nov 2022)
Last valuation:
USD 6.1 mn (Mar 2017)
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.